Clinical Trial Results

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

PHASE2INTERVENTIONAL Boston, Massachusetts +4 more

RECRUITING

NARCOMS Registry: A Multiple Sclerosis Registry

N/AOBSERVATIONAL Dallas, Texas

RECRUITING

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

PHASE3INTERVENTIONAL Palo Alto, California +4 more

RECRUITING

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

NAINTERVENTIONAL Richardson, Texas

RECRUITING

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

PHASE3INTERVENTIONAL Cullman, Alabama +4 more

RECRUITING